Lyme Disease Testing Market
Lyme Disease Testing Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Lyme Disease Testing Market Size and Growth
The Lyme Disease Testing market is experiencing significant growth, driven by rising incidence rates and heightened awareness. Valued at approximately $600 million in 2023, the market is projected to expand due to innovations in diagnostic technologies and increased funding for research, enhancing early detection and treatment options.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Quidel Corporation
◍ Roche Holding AG
◍ Fujirebio(H.U. Group Holdings)
◍ ZEUS Scientific
◍ IGeneX
◍ Thermo Fisher Scientific
◍ Everlywell
The Lyme Disease Testing Market features major players like Quidel, Roche, and IGeneX, offering diagnostics that enhance detection accuracy. Their innovative solutions and partnerships drive market growth. For instance, Thermo Fisher reported $39 billion in revenue, while BioRad generated $2.5 billion, underscoring the market's significant economic potential.
◍ Oxford Immunotec Global PLC(PerkinElmer)
◍ BioMerieux
◍ Bio-Rad Laboratories
◍ T2 Biosystems
Request Sample Report
Market Segmentation
By Application
Hospital and Testing Agency
Personal
Request Sample Report
By Product
ELISA
Western Blotting
PCR
Others
Market Growth
Request Sample Report
$ X Billion USD
